Pelassy C, Cattan N, Aussel C
Unité de Recherches en Immunologie Cellulaire et Moléculaire, INSERM U210, Faculté de Médecine, Nice, France.
Biochem J. 1992 Mar 1;282 ( Pt 2)(Pt 2):443-6. doi: 10.1042/bj2820443.
Quinine, 4-aminopyridine and tetraethylammonium, three compounds generally used as effectors of K+ channels, strongly modify phospholipid metabolism. In the human monocytic cell line THP1, the three drugs enhanced the incorporation of [3H]serine into phosphatidylserine and that of [3H]inositol into phosphatidylinositol in the absence of significant changes in the uptake of the 3H labels. On the contrary, the biosynthesis of both phosphatidylcholine and phosphatidylethanolamine was strongly inhibited. This inhibition appeared to be mainly due to the inhibition of both [3H]choline and [3H]ethanolamine uptake by the cells, by impairment of choline transport in a competitive mode.
奎宁、4-氨基吡啶和四乙铵这三种通常用作钾通道效应剂的化合物,会强烈改变磷脂代谢。在人单核细胞系THP1中,这三种药物在3H标记物摄取无显著变化的情况下,增强了[3H]丝氨酸掺入磷脂酰丝氨酸以及[3H]肌醇掺入磷脂酰肌醇的过程。相反,磷脂酰胆碱和磷脂酰乙醇胺的生物合成均受到强烈抑制。这种抑制似乎主要是由于细胞对[3H]胆碱和[3H]乙醇胺摄取的抑制,其通过竞争性方式损害胆碱转运。